Hyperbaric oxygen therapy
Breathing supplemental oxygen at above-normal pressure in a chamber.
Recovery practices
Research records
Historical source snapshot. Not freshly verified, not a recommendation. Study findings, community accounts and app defaults are not interchangeable.
Publication suitability · 2026-10-15: Historical reference only; not a clinical verification. Clinical, regulatory, efficacy, safety and dose claims are not independently established by this review.
Hyperbaric oxygen therapy
Breathing supplemental oxygen at above-normal pressure in a chamber.
Evidence category: Clinical study. This describes the source category, not approval or certainty.
Regulatory statement in source: Not separately recorded; do not infer approval from the evidence category.
A prospective crossover clinical trial tested hyperbaric oxygen therapy in sixty women diagnosed with fibromyalgia syndrome, pairing symptom and quality-of-life measures with brain imaging. The treated group showed improvement across fibromyalgia symptoms alongside measurable changes in brain activity patterns linked to pain processing.
Benefits reported in the imported source
- Hyperbaric oxygen therapy was linked with significant improvement in fibromyalgia symptoms and quality-of-life measures in this crossover trial.
- Brain imaging in the treated group showed rectification of abnormal activity patterns linked to pain processing.
- The crossover design let each participant serve as their own control, strengthening the comparison.
Risks and limits
- The no-treatment control period showed no improvement, underscoring that benefits were specific to the oxygen therapy sessions rather than to time or attention alone.
- The trial enrolled only sixty female patients from a single center, limiting how broadly the findings generalize.
- Hyperbaric chambers carry known risks including barotrauma and oxygen toxicity that are not addressed by this trial's design.
Source bottom line: A prospective crossover trial found a forty-session hyperbaric oxygen protocol linked with improved fibromyalgia symptoms and altered brain activity patterns, based on a small single-center sample.
Uncertainty: Reference information only. Not medical advice.
Study protocols — reports, not instructions
60 female patients aged 21 to 67 diagnosed with fibromyalgia syndrome for at least two years
- Reported regimen
- Forty hyperbaric oxygen sessions delivered five days a week, ninety minutes each, breathing pure oxygen at two atmospheres absolute, compared against a no-treatment control period
- Duration
- Forty-session protocol delivered over eight weeks, with crossover-control comparison
- Reported outcome
- Hyperbaric oxygen therapy was linked with significant improvement in fibromyalgia symptoms and quality of life, alongside rectification of abnormal brain activity patterns on imaging, while the no-treatment control period showed no improvement
- Source
- Hyperbaric oxygen therapy can diminish fibromyalgia syndrome--prospective clinical trial
Claim provenance
evidence.json#/catalog:recovery:hyperbaric-oxygen/protocols/0
Community and practice descriptions
Accounts of a practice are not evidence of safety or effectiveness. Words such as “standard”, “safe” or “recommended” describe the source account, not verified consensus or this wiki’s advice. Commercial and self-published citations are retained for traceability, not vendor endorsement or independent clinical corroboration.
Unverified imported account — Hyperbaric oxygen therapy: Evidence-based uses and unproven claims - Harvard Health
An imported authored paraphrase, not a quotation or a recommended protocol.
Review: unverified historical account. The imported wording is preserved for attribution; its full clinical, dosing, efficacy or consensus claims have not been independently established. Described practice context only; no clinical benefit or safety outcome is inferred.
Imported wording: Harvard Health reports some treatment centres marketing hyperbaric oxygen for uses beyond FDA-cleared indications, distinguishing those claims from established medical uses.
Hyperbaric oxygen therapy: Evidence-based uses and unproven claims - Harvard Health
Historical research outcome: verified-description · 2026-10-06
An attributed practice description was verified without importing the source's benefit claims, recommendations or assumptions about prevalence.
- https://www.health.harvard.edu/healthy-aging-and-longevity/hyperbaric-oxygen-therapy-evidence-based-uses-and-unproven-claims: verified-description — Independently read the live source and checked this limited, attributed description: Harvard Health reports some treatment centres marketing hyperbaric oxygen for uses beyond FDA-cleared indications, distinguishing those claims from established medical uses.
Pharmacokinetic context
No half-life recorded in this source snapshot. No value has been inferred.
Source references
Snapshot provenance
Source ID: catalog:recovery:hyperbaric-oxygen. Commit: adc7684614f9439b41d91a3312b62e7982c7e20e. Review state: historical-not-reverified. Authored links are retained separately from the canonical evidence links in the public data. App templates/defaults and rejected drafts are archived, not deployed.
Related entries and components
None listed.